Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
International Journal of Clinical Oncology|April 29, 2017
Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 casesYusuke Tanaka, Yutaka Ueda, Mamoru Kakuda, et al.
Clinical & Experimental Metastasis|October 8, 2015
The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancerTakeshi Hisamatsu, Seiji Mabuchi, Tomoyuki Sasano, et al.
International Journal of Clinical Oncology|November 13, 2020
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, JapanSeiji Mabuchi, Misa Yamamoto, Hiroko Murata, et al.
Scientific Reports|March 14, 2025
Roles of C-reactive protein and LOX-1 on cancer and myeloid-derived suppressor cells in the progression of uterine cervical cancerMichihide Maeda, Seiji Mabuchi, Takashi Akazawa, et al.
Oncotarget|April 9, 2019
Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental modelsKatsumi Kozasa, Seiji Mabuchi, Yuri Matsumoto, et al.
Cancer Medicine|January 24, 2013
Significance of lymphovascular space invasion in epithelial ovarian cancerKoji Matsuo, Todd B Sheridan, Kiyoshi Yoshino, et al.
Oncotarget|December 18, 2018
Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancerHiromasa Kuroda, Seiji Mabuchi, Eriko Yokoi, et al.
The Journal of Biological Chemistry|August 15, 2003
Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell lineJun Kawagoe, Masahide Ohmichi, Toshifumi Takahashi, et al.
The Journal of Biological Chemistry|March 18, 2004
Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer modelsSeiji Mabuchi, Masahide Ohmichi, Yukihiro Nishio, et al.
Oncotarget|November 23, 2017
Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal disseminationErika Nakatsuka, Kenjiro Sawada, Koji Nakamura, et al.
Pageof 19